BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21884794)

  • 1. IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice.
    Tsai LK; Chen YC; Cheng WC; Ting CH; Dodge JC; Hwu WL; Cheng SH; Passini MA
    Neurobiol Dis; 2012 Jan; 45(1):272-9. PubMed ID: 21884794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.
    Passini MA; Bu J; Roskelley EM; Richards AM; Sardi SP; O'Riordan CR; Klinger KW; Shihabuddin LS; Cheng SH
    J Clin Invest; 2010 Apr; 120(4):1253-64. PubMed ID: 20234094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
    Dominguez E; Marais T; Chatauret N; Benkhelifa-Ziyyat S; Duque S; Ravassard P; Carcenac R; Astord S; Pereira de Moura A; Voit T; Barkats M
    Hum Mol Genet; 2011 Feb; 20(4):681-93. PubMed ID: 21118896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy.
    Simon CM; Jablonka S; Ruiz R; Tabares L; Sendtner M
    Hum Mol Genet; 2010 Mar; 19(6):973-86. PubMed ID: 20022887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy.
    Tsai LK; Tsai MS; Ting CH; Wang SH; Li H
    Neurobiol Dis; 2008 Sep; 31(3):361-7. PubMed ID: 18590823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Grohmann K; Rossoll W; Kobsar I; Holtmann B; Jablonka S; Wessig C; Stoltenburg-Didinger G; Fischer U; Hübner C; Martini R; Sendtner M
    Hum Mol Genet; 2004 Sep; 13(18):2031-42. PubMed ID: 15269181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1:tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice.
    Chian RJ; Li J; Ay I; Celia SA; Kashi BB; Tamrazian E; Matthews JC; Bronson RT; Rossomando A; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Brain Res; 2009 Sep; 1287():1-19. PubMed ID: 19563785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.
    Passini MA; Bu J; Richards AM; Treleaven CM; Sullivan JA; O'Riordan CR; Scaria A; Kells AP; Samaranch L; San Sebastian W; Federici T; Fiandaca MS; Boulis NM; Bankiewicz KS; Shihabuddin LS; Cheng SH
    Hum Gene Ther; 2014 Jul; 25(7):619-30. PubMed ID: 24617515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a standardized therapeutic testing protocol for spinal muscular atrophy.
    Tsai LK; Tsai MS; Lin TB; Hwu WL; Li H
    Neurobiol Dis; 2006 Nov; 24(2):286-95. PubMed ID: 16952456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IPLEX administration improves motor neuron survival and ameliorates motor functions in a severe mouse model of spinal muscular atrophy.
    Murdocca M; Malgieri A; Luchetti A; Saieva L; Dobrowolny G; de Leonibus E; Filareto A; Quitadamo MC; Novelli G; Musarò A; Sangiuolo F
    Mol Med; 2012 Sep; 18(1):1076-85. PubMed ID: 22669476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I: potential for treatment of motor neuronal disorders.
    Lewis ME; Neff NT; Contreras PC; Stong DB; Oppenheim RW; Grebow PE; Vaught JL
    Exp Neurol; 1993 Nov; 124(1):73-88. PubMed ID: 8282084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy.
    Rindt H; Buckley DM; Vale SM; Krogman M; Rose FF; Garcia ML; Lorson CL
    Neuromuscul Disord; 2012 Mar; 22(3):277-85. PubMed ID: 22079083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation.
    Martínez-Hernández R; Soler-Botija C; Also E; Alias L; Caselles L; Gich I; Bernal S; Tizzano EF
    J Neuropathol Exp Neurol; 2009 May; 68(5):474-81. PubMed ID: 19525895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor 1 prevents neuronal cell death and paraplegia in the rabbit model of spinal cord ischemia.
    Nakao Y; Otani H; Yamamura T; Hattori R; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jul; 122(1):136-43. PubMed ID: 11436046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy.
    Bowerman M; Murray LM; Boyer JG; Anderson CL; Kothary R
    BMC Med; 2012 Mar; 10():24. PubMed ID: 22397316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1.
    Krieger F; Elflein N; Saenger S; Wirthgen E; Rak K; Frantz S; Hoeflich A; Toyka KV; Metzger F; Jablonka S
    Brain; 2014 May; 137(Pt 5):1374-93. PubMed ID: 24681663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice.
    Tsai LK; Chen CL; Ting CH; Lin-Chao S; Hwu WL; Dodge JC; Passini MA; Cheng SH
    Mol Ther; 2014 Aug; 22(8):1450-1459. PubMed ID: 24814151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of PEGylated insulin-like growth factor I in the pmn mouse model of motoneuron disease.
    Jablonka S; Holtmann B; Sendtner M; Metzger F
    Exp Neurol; 2011 Dec; 232(2):261-9. PubMed ID: 21963648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole attenuates spinal muscular atrophy disease progression in a mouse model.
    Haddad H; Cifuentes-Diaz C; Miroglio A; Roblot N; Joshi V; Melki J
    Muscle Nerve; 2003 Oct; 28(4):432-7. PubMed ID: 14506714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.